Corrigendum to "Dually modified transmembrane proteoglycans in development and disease" [Cytokine Growth Factor Rev. 39 (2018) 124-136].

Jenkins, Laura M; Horst, Ben; Lancaster, Carly L; Mythreye, Karthikeyan

Corrigendum to "Dually modified transmembrane proteoglycans in development and disease" [Cytokine Growth Factor Rev. 39 (2018) 124-136].

Jenkins, Laura M; Horst, Ben; Lancaster, Carly L; Mythreye, Karthikeyan.

Afiliación

Jenkins LM; Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA.
Horst B; Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA.
Lancaster CL; Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA.
Mythreye K; Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA; Department of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA. Electronic address: Mythreye@sc.edu.

Cytokine Growth Factor Rev ; 67: 105, 2022 Oct.

Article en En | MEDLINE | ID: mdl-36008226

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cytokine Growth Factor Rev Asunto de la revista: ALERGIA E IMUNOLOGIA / BIOQUIMICA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google